We are live on ! Find out more
SK

Sarah Ketterer Causeway Capital Management

AUM $9.24B
1-Year Est. Return 21.27%
 

Sarah Ketterer is co-founder and CEO of Causeway Capital Management, a firm specializing in international and global value equities. Causeway is known for disciplined valuation work across developed and emerging markets. Ketterer’s commentary is often sought for perspective on non-U.S. equities, currencies, and relative value abroad.

This Fund
S&P 500
This Quarter Est. Return
-5.89%
1 Year Est. Return
+21.27%
3 Year Est. Return
+72.78%
5 Year Est. Return
+71.25%
10 Year Est. Return
+497.07%
AUM
$4.39B
AUM Growth
+$322M
Cap. Flow
+$590M
Cap. Flow %
13.42%
Top 10 Hldgs %
53.58%
Holding
119
New
22
Increased
41
Reduced
39
Closed
12

Sector Composition

Rank Sector Weight
1 Industrials 27.5%
2 Technology 19.8%
3 Financials 13.03%
4 Healthcare 10.68%
5 Consumer Discretionary 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
26
Pfizer
PFE
$160B
$48.6M 1.11%
1,832,790
-378,520
-17% -$10.3M
ORCL icon
27
Oracle
ORCL
$422B
$48.4M 1.1%
290,613
-106,743
-27% -$19M
DGX icon
28
Quest Diagnostics
DGX
$27B
$45.9M 1.05%
304,481
-37,579
-11% -$5.84M
SAP icon
29
SAP
SAP
$252B
$43.8M 1%
177,860
-1,188
-0.7% -$283K
PDD icon
30
Pinduoduo
PDD
$126B
$43.3M 0.99%
446,272
-322,505
-42% -$37.5M
BIIB icon
31
Biogen
BIIB
$32B
$43.1M 0.98%
+281,702
New +$47.5M
PHG icon
32
Philips
PHG
$26.8B
$39.7M 0.9%
1,693,778
+328,009
+24% +$8.47M
BP icon
33
BP
BP
$115B
$38.5M 0.88%
1,302,058
+117,605
+10% +$3.53M
DEO icon
34
Diageo
DEO
$52.6B
$37.5M 0.85%
294,763
-2,164
-0.7% -$275K
GSK icon
35
GSK
GSK
$105B
$36.4M 0.83%
1,076,580
+179,174
+20% +$6.45M
JLL icon
36
Jones Lang LaSalle
JLL
$17.8B
$34.1M 0.78%
134,579
-50,163
-27% -$13.4M
PUK icon
37
Prudential
PUK
$35B
$34.1M 0.78%
2,136,842
+73
+0% +$1.22K
CFG icon
38
Citizens Financial Group
CFG
$29.4B
$33.5M 0.76%
764,553
-122,767
-14% -$5.43M
SNY icon
39
Sanofi
SNY
$110B
$33.3M 0.76%
690,436
+192,954
+39% +$9.81M
BAP icon
40
Credicorp
BAP
$30.1B
$31.1M 0.71%
169,568
+102,101
+151% +$19.1M
APTV icon
41
Aptiv
APTV
$10B
$30.8M 0.7%
509,649
+36,760
+8% +$2.25M
LYV icon
42
Live Nation Entertainment
LYV
$42.4B
$30.5M 0.69%
235,621
-233,506
-50% -$29.4M
BUD icon
43
AB InBev
BUD
$155B
$28.8M 0.65%
574,298
+65,691
+13% +$3.8M
MT icon
44
ArcelorMittal
MT
$54.4B
$24.7M 0.56%
1,067,400
+121,155
+13% +$2.99M
ING icon
45
ING
ING
$99.5B
$23.4M 0.53%
1,491,567
+416,762
+39% +$6.77M
BTI icon
46
British American Tobacco
BTI
$121B
$22.9M 0.52%
629,912
-124,989
-17% -$4.51M
WB icon
47
Weibo
WB
$1.73B
$21.6M 0.49%
2,259,267
+292,086
+15% +$2.8M
RELX icon
48
RELX
RELX
$62.6B
$21.2M 0.48%
465,886
+41,476
+10% +$1.94M
XP icon
49
XP
XP
$8.53B
$20.5M 0.47%
+1,728,899
New +$27.2M
SE icon
50
Sea Limited
SE
$72B
$19.7M 0.45%
+185,494
New +$19.5M

Similar funds

Sarah Ketterer's Q4 2024 Portfolio in Review

As of Q4 2024, Sarah Ketterer held 119 positions worth $4.39B, up 7.9% from $4.07B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Sarah Ketterer deployed $590M of net new capital in Q4 2024, opening 22 new positions and adding to 41 existing holdings. Its largest new stake was Barrick Mining: 11,112,293 shares worth $172M.

By sector, the portfolio is most concentrated in Industrials at 28% of assets, up from 19% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $98.7M trimmed.

  • Sarah Ketterer's largest Q4 2024 buy was Barrick Mining: 11,112,293 shares worth $172M.
  • Sarah Ketterer added most to Canadian Pacific Kansas City in Q4 2024, an estimated $515M increase.
  • Sarah Ketterer's biggest Q4 2024 reduction was iShares MSCI EAFE ETF, cutting an estimated $98.7M.
  • Sarah Ketterer fully exited Fiserv Inc in Q4 2024, selling an estimated $52.5M.
  • Sarah Ketterer's ten largest holdings make up 54% of its $4.39B portfolio in Q4 2024.
  • Sarah Ketterer opened 22 new positions and closed 12 in Q4 2024.
  • Sarah Ketterer's portfolio value rose 7.9% quarter-over-quarter to $4.39B.

Based on Causeway Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.